Shahnazi Mahnaz, Bayatipayan Somaye, Khalili Azizeh Farshbaf, Kochaksaraei Fatemeh Ranjbar, Jafarabadi Mohammad Asghari, Banoi Kamala Gaza, Nahaee Jila
Department of Midwifery, Faculty of Nursing and Midwifery, Tabriz University of Medical Sciences, Tabriz, Iran.
Department of Psychiatry, Tabriz University of Medical Sciences, Tabriz, Iran.
Iran J Nurs Midwifery Res. 2015 Jan-Feb;20(1):47-55.
The aim of this study was to compare the effects of the second- and third-generation oral contraceptives on women's reproductive sexual function.
This randomized, double-blind, placebo-controlled clinical trial was conducted on 82 married women of reproductive age in Tehran. Samples were randomized into the groups receiving second- and third-generation oral contraceptive pills. Female Sexual Function Index (FSFI) tool was used before the intervention and 2 and 4 months after the intervention. Data analysis was carried out using analysis of variance (ANOVA) within repeated measures and P < 0.05 were considered significant.
There was a statistically significant difference in the positive and negative moods between the experimental and control groups before the intervention in the second and fourth months. The second-generation pills caused a decrease in sexual function in the second month and an increase in sexual function in the fourth month, but the third-generation pills led to an increase in sexual function in the second and fourth months. The increase in sexual function that resulted from using the third-generation pills was significantly higher than that resulted on using the second-generation pills.
According to the results of this study, sexual functioning decreased in the second month of using the second-generation pills and sexual performance was significantly more on using the third-generation pills compared to second-generation pills. The most common type of oral contraceptive used in Iran is the second-generation oral contraceptive LD™ (low-dose estrogen), which is freely distributed in health centers. Therefore, it is necessary for women who wish to use these contraceptive methods to be educated and consulted before they start using them. The third-generation contraceptive pills can be recommended to women who wish to use oral contraceptives.
本研究旨在比较第二代和第三代口服避孕药对女性生殖性功能的影响。
这项随机、双盲、安慰剂对照的临床试验在德黑兰82名育龄已婚妇女中进行。样本被随机分为接受第二代和第三代口服避孕药的组。在干预前以及干预后2个月和4个月使用女性性功能指数(FSFI)工具。使用重复测量方差分析(ANOVA)进行数据分析,P<0.05被认为具有统计学意义。
在第二个月和第四个月干预前,实验组和对照组之间的正负情绪存在统计学显著差异。第二代避孕药在第二个月导致性功能下降,在第四个月导致性功能增加,但第三代避孕药在第二个月和第四个月导致性功能增加。使用第三代避孕药导致的性功能增加显著高于使用第二代避孕药导致的增加。
根据本研究结果,使用第二代避孕药的第二个月性功能下降,与第二代避孕药相比,使用第三代避孕药时性功能表现明显更好。伊朗最常用的口服避孕药类型是第二代口服避孕药LD™(低剂量雌激素),在健康中心免费发放。因此,希望使用这些避孕方法的女性在开始使用前有必要接受教育和咨询。可以向希望使用口服避孕药的女性推荐第三代避孕药。